Skip to main content

Table 3 Measures of self-efficacy

From: Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine

  Antenatal survey Postnatal survey
  Confident could do Fairly confident could do Could not do Confident could do Fairly confident could do Could not do
ART-related self-efficacy       
1. Keep taking ART if side effects interfere 40% (68/171) 46% (78/171) 15% (25/171) 29% (26/89) 51% (45/89) 20% (18/89)
2. Keep taking ART in front of people unaware of your HIV status 43% (75/175) 46% (81/175) 11% (19/175) 31% (27/88) 59% (52/88) 10% (9/88)
3. Keep taking ART if daily routine disrupted 45% (78/173) 47% (81/173) 8% (14/173) 41% (35/86) 57% (49/86) 2% (2/86)
4. Keep taking ART if not feeling well 43% (77/178) 47% (83/178) 10% (18/178) 24% (20/85) 62% (53/85) 14% (12/85)
5. Keep attending appointments if they interfere with daily activities 36% (54/148) 55% (82/148) 8% (12/148) 45% (32/71) 52% (37/71) 3% (2/71)
Proportion reporting that they could not do ≥1 of 5 ART-related items 20% (28/141)    17% (11/66)   
Help-seeking self-efficacy       
1. Ask clinician for more information or tell them about concerns or worries 37% (61/167) 56% (94/167) 7% (12/167) 48% (41/86) 49% (42/86) 3% (3/86)
2. Ask someone for support with taking medication if needed 33% (54/165) 47% (78/165) 20% (33/165) 30% (26/86) 43% (37/86) 27% (23/86)